ABT vs. IDXX: Abbott Laboratories vs. IDEXX Laboratories Stock Comparison

Company Profile

Abbott Laboratories (ABT) and IDEXX Laboratories (IDXX) are both classified in the Health Care Equipment sub-industry within the broader Health Care Equipment & Supplies industry, placing them in the closest GICS peer bucket.

Price Performance

Cumulative Growth

Trailing Returns

Calendar-Year Returns

Performance Metrics

Risk Profile

Drawdown History

Return Distribution

Risk Metrics

IDEXX Laboratories (IDXX) has an aggressive beta of 1.44, indicating higher sensitivity to broad-market moves, while Abbott Laboratories (ABT) is defensive at 0.53 and tends to be less market-sensitive — they sit on opposite ends of the beta spectrum.

Risk-Adjusted Performance

Risk-Return Positioning

Risk-Adjusted Metrics

Profitability

IDEXX Laboratories (IDXX) at 68.93% clears its industry range for ROE, a sharper capital-efficiency signal than Abbott Laboratories (ABT) at 9.14%, which is closer to a typical peer reading.

For every dollar of sales, both Abbott Laboratories (ABT) at 9.75% and IDEXX Laboratories (IDXX) at 25.36% retain more as net profit than most peers, landing in the top net margin quartile of their industries.

IDEXX Laboratories (IDXX) at 33.14% operates in the top operating margin quartile, ahead of Abbott Laboratories (ABT) at 11.66%, which runs around its industry’s norm.

Profitability Metrics

Growth

Both Abbott Laboratories (ABT) at 5.67% and IDEXX Laboratories (IDXX) at 10.42% land near their industries' usual revenue growth ranges, so top-line momentum looks broadly in line with peers on both sides.

IDEXX Laboratories (IDXX) at 22.59% is around its peer norm for EPS growth, while Abbott Laboratories (ABT) at -51.31% drops into the bottom quartile, signaling weaker earnings momentum.

Growth Metrics

Financial Strength

Abbott Laboratories (ABT) at 1.46 keeps current ratio within its industry’s typical mid-range, while IDEXX Laboratories (IDXX) at 1.19 runs in the tighter-liquidity quartile — a thinner cushion against current liabilities for IDXX.

Both Abbott Laboratories (ABT) at 0.61 and IDEXX Laboratories (IDXX) at 0.52 fund their balance sheets with roughly industry-typical debt-to-equity mixes.

Financial Strength Metrics

Dividends

IDEXX Laboratories (IDXX) pays no dividend (yield 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile Abbott Laboratories (ABT) reports a yield of 2.22%, ranking against industry peers normally.

IDEXX Laboratories (IDXX) pays no dividend (payout 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile Abbott Laboratories (ABT) reports a payout of 92.54%, ranking against industry peers normally.

Dividend Metrics

Valuation

Both Abbott Laboratories (ABT) at 41.02 and IDEXX Laboratories (IDXX) at 45.56 land around their industries’ usual P/E ratio levels — neither is getting a clear earnings-multiple discount or premium versus peers.

Abbott Laboratories (ABT) at 3.95 prices around its industry’s typical P/S ratio, while IDEXX Laboratories (IDXX) at 11.42 clears its benchmark range — IDXX looks notably rich on sales.

Abbott Laboratories (ABT) at 3.73 sits near its industry’s typical P/B ratio, while IDEXX Laboratories (IDXX) at 28.50 prices above its benchmark range — IDXX looks rich relative to book.

Valuation Metrics